Back to Search Start Over

1600P Phase II trial of pembrolizumab and lenvatinib in advanced neuroendocrine prostate cancer (NEPC).

Authors :
Vaishampayan, U.N.
Kilari, D.
Dorff, T.B.
Taylor, J.
Brown, J.T.
Sokolova, A.O.
Reichert, Z.
Palmbos, P.
Tsung, I.
Caram, M.
Yentz, S.
Alumkal, J.
Nazha, B.
Source :
Annals of Oncology. 2024 Supplement 2, Vol. 35, pS965-S965. 1p.
Publication Year :
2024

Subjects

Subjects :
*PROSTATE cancer
*PEMBROLIZUMAB

Details

Language :
English
ISSN :
09237534
Volume :
35
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
179693043
Full Text :
https://doi.org/10.1016/j.annonc.2024.08.1681
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details